Sign In
NewsRadar

Syntarga BV (acquired by Synthon)

Biopharmaceutical company that develops linker technologies for bioconjugation, as well as targeted anticancer products. The technologies enable efficient and specific drug release from targeted bioconjugates, improving the drug’s efficacy and diminishing its side effects. The company’s product development activities focus on novel tumor-specific medicines, reducing side-effects of current cancer chemotherapy and improving therapeutic window.

• Show past press releases
• Edit this company

Elevator Pitch
Syntarga has a strong and unique IP position in the area of linker technologies and chemistries. Proof of concept has been established in vitro and in vivo in multiple animal models. Syntarga has a knowledgeable management team, supported by an experienced (business & scientific) advisory board.

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Toernooiveld 1
Nijmegen 6525 ED
Netherlands
+31 (0)24 3652 878
N/A
http://www.syntarga.com
Vincent de Groot
+31 (0)24 3652 878

Company Facts
Founded:Dec 2002
Founders:Dr. Vincent F.M.H. de Groot, Dr. Patrick H. Beusker
CEO:Vincent de Groot
CTO or technical lead:
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:Early Stage
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:4
Profitability:Pre-revenue
Funding raised:Yes
Funding sought:Yes
Seeking Partnerships:Yes

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


26,442
Tech investments
From our Online Data Service
17,073
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 6€9.3MSoftware development
Dec 6€1.5MConsumer applications
Dec 6€3.7MInternet commerce
Dec 5€8.0MNanotechnology
Dec 5€11.0MBiotechnology
Dec 5€11.0MRobotics
Dec 5N/ARobotics

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...





About usContact usLegal Information
Copyright 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.